Sun Pharma, an Indian medical products firm, is combining manufacturing operations currently located in New Brunswick and Cranbury, potentially costing nearly 100 workers their jobs.
Sun Pharma issued a federal WARN notice saying 96 positions were at risk of elimination at the Cranbury facility. Jobs slated for layoffs at various times in 2019 include packaging and other operators, chemists, mechanics and others.
“Sun Pharma is consolidating its manufacturing operations at New Brunswick and Cranbury into one location, New Brunswick,” a company spokesperson said in a statement emailed to ROI-NJ. “As part of this process, the operations at Cranbury, including inventory, products, manufacturing and lab equipment, are being transferred to New Brunswick. The restructuring is aimed at optimizing our manufacturing operations and improving cost efficiencies in the increasingly competitive U.S. market.
“We are offering full support to the employees at Cranbury and helping them with internal reallocations and outplacement services.”
Those laid off would receive severance and other benefits, according to the notice.
WARN notices normally cover mass layoffs or facility closings as part of the Worker Adjustment and Retraining Notification Act of 1989.
